Barclays raised the firm’s price target on DexCom (DXCM) to $93 from $90 and keeps an Equal Weight rating on the shares. The firm made “elatively minor changes” to its model to reflect the company’s Q1 results and revised 2025 guidance.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM: